The new NIH policy focuses on enhancing the quality and accessibility of datasets for reuse and analysis. It aligns with AI/ML advancements that allow for the integration and analysis of large, complex datasets. These technologies can help advance medication development, from repurposing drugs to predicting side effects. This is especially relevant for developing new treatments for substance use disorders.

The new NIH policy on Data Management and Sharing will further amplify this trend, increasing the quality and accessibility of high-value datasets available for reuse and secondary analysis. Concomitantly, advances in artificial intelligence/machine learning (AI/ML) enable integration and analys… Show More